Dose-Response Effects of Whole Body Vibration on Spasticity and Walking in SCI
Status: | Recruiting |
---|---|
Conditions: | Hospital, Orthopedic |
Therapuetic Areas: | Orthopedics / Podiatry, Other |
Healthy: | No |
Age Range: | 16 - 72 |
Updated: | 8/19/2018 |
Start Date: | January 2015 |
End Date: | August 2020 |
Contact: | Edelle Field-Fote, PT, PhD |
Email: | Edelle_Field-Fote@Shepherd.org |
Phone: | 404-603-4274 |
This study will enroll people with SCI who have spasticity and some ability to walk. The goal
is to understand if standing on a platform and receiving WBV results in decreased spasticity
and improved walking ability. Published article is available (PMID: 29959653)
is to understand if standing on a platform and receiving WBV results in decreased spasticity
and improved walking ability. Published article is available (PMID: 29959653)
Phase 1 of this study has been successfully completed. The results of Phase 1 indicate that a
single session of WBV lasting for a total of 6 minutes (delivered in eight 45-sec bouts) at a
high-frequency (50Hz) was associated with the largest decrease in spasticity (as measured by
the pendulum test).
The goal for Phase 2 is to determine whether longer doses of WBV result in greater reductions
in spasticity as well as improvements in walking ability. Two different doses of WBV, a short
dose and a long dose, will be tested.
single session of WBV lasting for a total of 6 minutes (delivered in eight 45-sec bouts) at a
high-frequency (50Hz) was associated with the largest decrease in spasticity (as measured by
the pendulum test).
The goal for Phase 2 is to determine whether longer doses of WBV result in greater reductions
in spasticity as well as improvements in walking ability. Two different doses of WBV, a short
dose and a long dose, will be tested.
Inclusion Criteria:
- have spinal cord injury of at least 6 months duration.
- be between the ages of 16 - 72 years old.
- be able to sit at the edge of the mat without the assistance of another person.
- be able to tolerate standing.
- have at least mild spasticity affecting the lower extremity muscles.
- be able to understand and provide own consent
- You may participate if you use prescription medications, including baclofen pump for
control of spasticity, as the dosage is stable.
- obtain medical clearance for standing if you have been injured more than 1 year and
are not regularly walking or standing.
Exclusion Criteria:
- progressive or potentially progressive spinal lesions, including degenerative, or
progressive vascular disorders of the spine and/or spinal cord.
- neurologic level below spinal level T12
- history of cardiovascular irregularities
- problems following instructions
- orthopedic problems that would limit your participation in the protocol (e.g. knee or
hip flexion contractures of greater than 10 degrees).
We found this trial at
1
site
Click here to add this to my saved trials